However, our findings using HNSCC cell lines have been corroborated by two recent studies showing that the cervical HPVU cell line C33A is preferentially sensitive to cyclin D1 inhibitors [41,42]. Here, CCND1 is linked to head and neck squamous cell carcinoma.